Latest Breaking News On - Diagnostic investigations - Page 2 : comparemela.com

FLORHAM PARK, N.J., Oct. 23, 2022 (GLOBE NEWSWIRE) Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases and disorders, announced

United statesRonnie fassCarmelo scarpignatoNick benedettoAzmi nabulsiDivision of gastroenterologyConsensus groupDigestive health center at metrohealth in clevelandCompany annual report on formExchange commissionAmerican college of gastroenterologyPhathom pharmaceuticals incPhathom pharmaceuticalsWorld organization for esophageal diseasesAmerican collegeScientific meeting